The Ascletis boss wants the biotech start-up to develop its own world-class drugs
Related Posts
Miners/iron ore: faltering Chinese demand highlights problems ahead
DealShot: 18 Deals Topping $1.43 Billion With Shenzhen Capital Group, Yunfeng Capital And Many Others
Patented Chinese medicine Lianhua Qingke Tablets entered the National Medical Insurance List-
KKR Names Ex-CEO Of China Development Financial As Head Of Greater China
Goldman Sachs And Temasek Invest $110M In Shanda's Cloudary
Tencent, Business Insider Ink Internet Content Deal For China
‘A kind of magic’: Peter Blake says possibilities of AI are endless for art
Xi and Pence spar over trade and security at Apec- China court sentences GSK investigator
‘Infinite appetite for beauty’ drives record sales at L’Oréal